Filtered By:
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 18794 results found since Jan 2013.
Risk of Hepatitis B Virus Reactivation in Patients with Resolved Infection on Therapy with Corticosteroids and Conventional Synthesis Immunosuppressants for Kidney Disease: A Single-Center Analysis of 258 Patients
CONCLUSIONS: Among patients with a previously resolved hepatitis B virus infection on therapy with corticosteroids and conventional synthesis immunosuppressants for kidney disease, hepatitis B virus reactivation was not common and severe, suggesting that universal prophylaxis may not be justified or cost-effective in this clinical setting.PMID:37681265 | DOI:10.5152/tjg.2023.22511
Source: The Turkish Journal of Gastroenterology - September 8, 2023 Category: Gastroenterology Authors: Pingyang Han Ziqiu Wang Zhaohui Wang Source Type: research
Immediate hypersensitivity to parenteral corticosteroids caused by IgE-mediated allergy to carmellose
J Investig Allergol Clin Immunol. 2023 Sep 6:0. doi: 10.18176/jiaci.0938. Online ahead of print.NO ABSTRACTPMID:37675798 | DOI:10.18176/jiaci.0938
Source: Journal of Investigational Allergology and Clinical Immunology - September 7, 2023 Category: Allergy & Immunology Authors: C Gal án A Arrien de Lecea B Bartolom é Zavala M P érez Escalera J S ánchez de Vicente Source Type: research
Implementation and Outcomes of an Empiric Ivermectin Strongyloides Treatment Protocol for Patients Receiving High-Dose Corticosteroids for Severe COVID-19
Am J Trop Med Hyg. 2023 Jul 17;109(3):650-655. doi: 10.4269/ajtmh.23-0121. Print 2023 Sep 6.ABSTRACTStrongyloides stercoralis is a parasitic roundworm that is present worldwide and can cause lifelong, often asymptomatic, infection. Immunosuppression, particularly by corticosteroids, is a risk factor for hyperinfection syndrome and disseminated strongyloidiasis-severe disease states that can lead to septic shock and death. Our institution implemented a strongyloidiasis screening and empiric ivermectin treatment protocol for inpatients receiving high-dose corticosteroids for severe COVID-19. Among 487 COVID-19 admissions tre...
Source: Am J Trop Med Hyg - September 7, 2023 Category: Infectious Diseases Authors: Benjamin Swart Aileen Ahiskali Jack M Wolf Megan Shaughnessy Source Type: research
Pneumothorax, pneumomediastinum, and subcutaneous emphysema in hospitalized COVID-19 patients: incidence, clinical characteristics, and outcomes
CONCLUSION: Although the occurrence of PTX/PNM/SCE in hospitalized COVID-19 patients was rare, it was associated with worse outcomes. Corticosteroids may contribute to the pathogenesis of these complications; however, further studies are needed to investigate this relationship in more detail.PMID:37675598 | DOI:10.1080/17476348.2023.2254689
Source: Respiratory Care - September 7, 2023 Category: Respiratory Medicine Authors: Aleksandra Murawska Baptista Jorge Sinclair De Fr ías Trisha Singh Ananya Vasudhar Jacob Guzzino Waheed Khalili Aysun Tekin Vikas Bansal Rahul Kashyap William J Joyce Patricia A Lewis Devang Sanghavi Tatjana Gavrancic Pablo Moreno Franco Source Type: research
Intravitreal immunotherapy in noninfectious uveitis: an update
Expert Rev Clin Pharmacol. 2023 Sep 6. doi: 10.1080/17512433.2023.2256660. Online ahead of print.ABSTRACTINTRODUCTION: In the past several years, there have been numerous advances in pharmacotherapeutics for the management of uveitis and other ocular inflammatory diseases, including newer therapeutic agents and ocular drug delivery systems. One of the most attractive modes of drug delivery is the intravitreal route since it has proven to be safe and efficacious and prevents unwanted systemic adverse events related to the agent.AREAS COVERED: In this review, intravitreal delivery of various pharmacotherapeutic agents for no...
Source: Pharmacological Reviews - September 7, 2023 Category: Drugs & Pharmacology Authors: Nitin Kumar Menia Sashwanthi Mohan Aniruddha Agarwal Source Type: research
Implementation and Outcomes of an Empiric Ivermectin Strongyloides Treatment Protocol for Patients Receiving High-Dose Corticosteroids for Severe COVID-19
Am J Trop Med Hyg. 2023 Jul 17;109(3):650-655. doi: 10.4269/ajtmh.23-0121. Print 2023 Sep 6.ABSTRACTStrongyloides stercoralis is a parasitic roundworm that is present worldwide and can cause lifelong, often asymptomatic, infection. Immunosuppression, particularly by corticosteroids, is a risk factor for hyperinfection syndrome and disseminated strongyloidiasis-severe disease states that can lead to septic shock and death. Our institution implemented a strongyloidiasis screening and empiric ivermectin treatment protocol for inpatients receiving high-dose corticosteroids for severe COVID-19. Among 487 COVID-19 admissions tre...
Source: The American Journal of Tropical Medicine and Hygiene - September 7, 2023 Category: Tropical Medicine Authors: Benjamin Swart Aileen Ahiskali Jack M Wolf Megan Shaughnessy Source Type: research
European Respiratory Society Short Guidelines for the use of as-needed ICS/formoterol in mild Asthma
Eur Respir J. 2023 Sep 7:2300047. doi: 10.1183/13993003.00047-2023. Online ahead of print.ABSTRACTRecent clinical trials of as-needed fixed-dose combination of ICS/formoterol have provided new evidence that may warrant a reconsideration of current practice.A task force (TF) was set up by the European Respiratory Society to provide evidence-based recommendations on the use of as-needed ICS/formoterol as treatment for mild asthma. The TF defined two questions that were assessed using the Grading of Recommendations, Assessment, Development and Evaluation approach. The TF utilised the outcomes to develop recommendations for a ...
Source: Respiratory Care - September 7, 2023 Category: Respiratory Medicine Authors: Alberto Papi Diogenes S Ferreira Ioana Agache Eugenio Baraldi Richard Beasley Guy Brusselle Courtney Coleman Mina Gaga Carolina Maria Gotera Rivera Erik Mel én Ian D Pavord Deborah Pe ñate Gómez Daniel Schuermans Antonio Spanevello Thomy Tonia Florence Source Type: research
Pneumothorax, pneumomediastinum, and subcutaneous emphysema in hospitalized COVID-19 patients: incidence, clinical characteristics, and outcomes
CONCLUSION: Although the occurrence of PTX/PNM/SCE in hospitalized COVID-19 patients was rare, it was associated with worse outcomes. Corticosteroids may contribute to the pathogenesis of these complications; however, further studies are needed to investigate this relationship in more detail.PMID:37675598 | DOI:10.1080/17476348.2023.2254689
Source: Respiratory Care - September 7, 2023 Category: Respiratory Medicine Authors: Aleksandra Murawska Baptista Jorge Sinclair De Fr ías Trisha Singh Ananya Vasudhar Jacob Guzzino Waheed Khalili Aysun Tekin Vikas Bansal Rahul Kashyap William J Joyce Patricia A Lewis Devang Sanghavi Tatjana Gavrancic Pablo Moreno Franco Source Type: research
Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
This article provides foundational knowledge on steroid-refractory (SR) aGVHD, current treatment options, and related supportive care.METHODS: Therapies for patients with SR aGVHD are summarized, along with supportive care recommendations and a review of related nursing considerations.FINDINGS: Current treatment and research on SR aGVHD offer opportunities for improved clinical outcomes for these patients. Nursing knowledge of the pathophysiology, treatment, and supportive care for patients with SR aGVHD is integral to the provision of optimal nursing care for a complex population of patients.PMID:37677777 | DOI:10.1188/23.CJON.397-403
Source: Clinical Journal of Oncology Nursing - September 7, 2023 Category: Nursing Authors: Naomi Cazeau Stephany L Rodriguez Source Type: research
Intravitreal immunotherapy in noninfectious uveitis: an update
Expert Rev Clin Pharmacol. 2023 Sep 6. doi: 10.1080/17512433.2023.2256660. Online ahead of print.ABSTRACTINTRODUCTION: In the past several years, there have been numerous advances in pharmacotherapeutics for the management of uveitis and other ocular inflammatory diseases, including newer therapeutic agents and ocular drug delivery systems. One of the most attractive modes of drug delivery is the intravitreal route since it has proven to be safe and efficacious and prevents unwanted systemic adverse events related to the agent.AREAS COVERED: In this review, intravitreal delivery of various pharmacotherapeutic agents for no...
Source: Pharmacological Reviews - September 7, 2023 Category: Drugs & Pharmacology Authors: Nitin Kumar Menia Sashwanthi Mohan Aniruddha Agarwal Source Type: research
Immediate hypersensitivity to parenteral corticosteroids caused by IgE-mediated allergy to carmellose
J Investig Allergol Clin Immunol. 2023 Sep 6:0. doi: 10.18176/jiaci.0938. Online ahead of print.NO ABSTRACTPMID:37675798 | DOI:10.18176/jiaci.0938
Source: Journal of Investigational Allergology and Clinical Immunology - September 7, 2023 Category: Allergy & Immunology Authors: C Gal án A Arrien de Lecea B Bartolom é Zavala M P érez Escalera J S ánchez de Vicente Source Type: research
Infectious complications among patients receiving ibrutinib for the treatment of hematological malignancies
CONCLUSION: Serious infection and IFI rates are high but similar to those previously described. Risk factors for serious infection included allo-HSCT and corticosteroid use. Targeted antimicrobial prophylaxis should be evaluated in prospective studies in patients on ibrutinib to reduce serious infections and IFI.PMID:37675967 | DOI:10.1093/ajhp/zxad210
Source: American Journal of Health-System Pharmacy : AJHP - September 7, 2023 Category: Drugs & Pharmacology Authors: Kenneth Tham Stacy Prelewicz Sara deHoll Deborah M Stephens Carlos A Gomez Source Type: research
